Sickle cell disease in India: Not just a mild condition

Area of Science:

• Hematology
• Global Health
• Public Health

Background:

• Sickle cell disease (SCD) is a major global health concern, affecting over 500,000 infants annually.
• While prevalent in sub-Saharan Africa, SCD's significant burden in India is often underestimated.
• SCD is frequently perceived as less severe in India, necessitating a re-evaluation of its impact.

Purpose of the Study:

• To assess the substantial impact of sickle cell disease on patients, families, and healthcare systems in India.
• To provide evidence supporting the recognition of SCD as a common and severe condition in India.
• To advocate for increased attention and resources for SCD management in India.

Main Methods:

• A national study was conducted in India to evaluate the burden of SCD.
• The study analyzed the impact of vaso-occlusive crisis, its management, and effects on quality of life.
• Data was collected to quantify the disease's reach across the Indian population.

Main Results:

• The study demonstrated a significant burden of SCD across patients, families, and the healthcare system in India.
• Findings challenge the notion that SCD is less severe in the Indian context.
• Vaso-occlusive crisis and its management present considerable challenges impacting patient quality of life.

Conclusions:

• Sickle cell disease poses a serious and common health challenge in India.
• There is a critical need for greater recognition and action to address SCD in India.
• The findings support a call to action for improved SCD care and public health strategies in India.